Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin in Liver Transplant Candidates (EPO-LT)
NCT07169643Phase 3Recruiting
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Nov 2025
- Primary completion
- Dec 2026
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of darbepoetin alfa in anemia (2 arms), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Intraoperative Red Blood Cell Concentrate Transfusion. Started Nov 2025; status: recruiting.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT07169643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07169643.